Theranostics and contrast-agents for medical imaging: a pharmaceutical company viewpoint.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

1. Recommendations from the Galician Oncological Society and the Galician Society of Nuclear Medicine for the use ofClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
   Guideline
2. Beyond radiotheranostics: how imaging modality defines theranostics.European radiology experimental · 2026
   Review
3. Theranostic Innovative Strategies for Brain Diseases: New Insights on Neurovascular Unit-Associated Pathological Changes in Neurodegenerative Disorders and Aging.International journal of molecular sciences · 2026
   Review
4. Companion Diagnostics in Clinical Therapy: Current Applications and Future Directions.MedComm · 2026
   Review
5. Tailoring Advanced Metal-Based Nanomedicines for Adaptable Nanodynamic Disease Therapies and Theranostics.Advanced materials (Deerfield Beach, Fla.) · 2026
   Review
6. The Novel Achievements in Oncological Metabolic Radio-Therapy: Isotope Technologies, Targeted Theranostics, Translational Oncology Research.Medical sciences (Basel, Switzerland) · 2025
   Review
7. Photodynamic and Photothermal Therapies using Nanotechnology Approach in Alzheimer's Disease.Current neuropharmacology · 2025
   Review
8. Innovative approaches in precision radiation oncology: advanced imaging technologies and challenges which shape the future of radiation therapy.Frontiers in medicine · 2025
   Review
9. Theranostics and Patient-Specific Dosimetry.Seminars in radiation oncology · 2023
   Review
10. Integrating Theranostics Into Patient Care Pathways:AJR. American journal of roentgenology · 2023
    Review
11. Toxics · 2023
    Review
12. Micro/Nanosystems for Magnetic Targeted Delivery of Bioagents.Pharmaceutics · 2022
    Review
13. Translating Biomarkers of Cholangiocarcinoma for Theranosis: A Systematic Review.Cancers · 2020
    Review
14. Functional probes for cardiovascular molecular imaging.Quantitative imaging in medicine and surgery · 2018
    Review
15. Rational design of a water-soluble NIR AIEgen, and its application in ultrafast wash-free cellular imaging and photodynamic cancer cell ablation.Chemical science · 2018
    Article
16. Studies towards elucidating the potential of 5,10,15,20-tetrakis(MedChemComm · 2018
    Article
17. Theranostics based on AIEgens.Theranostics · 2018
    Review
18. AIE-active theranostic system: selective staining and killing of cancer cells.Chemical science · 2017
    Article
19. A comprehensive literatures update of clinical researches of superparamagnetic resonance iron oxide nanoparticles for magnetic resonance imaging.Quantitative imaging in medicine and surgery · 2017
    Review
20. Imaging-guided delivery of RNAi for anticancer treatment.Advanced drug delivery reviews · 2016
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.